XM does not provide services to residents of the United States of America.
A
A

Amphenol

Trade Ideas

Traders Sentiment

Technical Summary

Hourly

News

Amphenol Corporation Completes Acquisition Of CIT Business From Carlisle

BRIEF-Amphenol Corporation Completes Acquisition Of CIT Business From Carlisle May 21 (Reuters) - Amphenol Corp APH.N : AMPHENOL CORPORATION COMPLETES ACQUISITION OF CIT BUSINESS FROM CARLISLE Source text for Eikon: ID:nBw4yMlT2a Further company coverage: APH.N
A

U.S. Arista Networks, Crescent Energy, Dell Technologies

U.S. RESEARCH ROUNDUP-Arista Networks, Crescent Energy, Dell Technologies May 20 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Arista Networks, Crescent Energy and Dell Technologies, on Monday. HIGHLIGHTS * Arista Networks Inc ANET.N : Evercore ISI raises target price to $340 from $320 * Crescent Energy Co CRGY.N : Gerdes Energy Research raises to buy from neutral * Dell Technologies Inc DELL.N : JP Morgan raises t
N
R
A
K
T
D
H
A
A
H

U.S. Bath & Body Works, Under Armour, Viking Therapeutics

U.S. RESEARCH ROUNDUP-Bath & Body Works, Under Armour, Viking Therapeutics May 17 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Bath & Body Works, Under Armour and Viking Therapeutics, on Friday. HIGHLIGHTS * Advanced Drainage Systems Inc WMS.N : Barclays raises target price to $202 from $189 * Bath & Body Works Inc BBWI.N : JP Morgan raises to neutral from underweight * Tanger Inc SKT.N : Scotiabank raises to sect
B
C
G
M
T
A
A
C
D
T

U.S. AN2 Therapeutics, Ecolab, RPM International

U.S. RESEARCH ROUNDUP-AN2 Therapeutics, Ecolab, RPM International May 16 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including AN2 Therapeutics, Ecolab and RPM International, on Thursday. HIGHLIGHTS * AN2 Therapeutics Inc ANTX.O : Evercore ISI cuts target price to $2 from $7 * Biolife Solutions Inc BLFS.O : Maxim Group raises target price to $30 from $25 * Ecolab Inc ECL.N : Evercore ISI raises target price to $250 from $1
C
A
D
E
A
C
E

US companies with highest exposure to China

FACTBOX-US companies with highest exposure to China May 14 (Reuters) - U.S. President Joe Biden on Tuesday unveiled a bundle of steep tariff increases on an array of Chinese imports including electric vehicles, computer chips and medical products, risking an election-year standoff with Beijing in a bid to woo voters who give his economic policies low marks.
A
I
T
L
M
T
A
B
K
M

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.